Featured Research

from universities, journals, and other organizations

Scientists Excited About Miniature Cooking Pots

Date:
July 14, 1998
Source:
Montana State University
Summary:
Most people have a favorite cooking pot, like a saute skillet with a wooden handle or a copper-bottomed sauce pan. Right now Mark Young is pretty excited about what may be nature's smallest cooking vessel--the round shell of a virus that's been emptied of the stuff that causes disease.

by Annette Trinity-Stevens

07/02/98 BOZEMAN -- Most people have a favorite cooking pot, like a saute skillet with a wooden handle or a copper-bottomed sauce pan.

Right now Mark Young is pretty excited about what may be nature's smallest cooking vessel--the round shell of a virus that's been emptied of the stuff that causes disease.

Young studies viruses at Montana State University-Bozeman. He and Temple University chemist Trevor Douglas have discovered that the protein case that encapsulates a virus can be hijacked when empty and used as a "molecular cooking pot" of the nanosphere size. That's one thousand millionth of a meter.

In this scenario, viruses would work for us. Such a minuscule vessel could travel inside the body and deliver a drug to the right cellular address, for example.

"What you have is a container," said Scripps Research Institute virologist Jack Johnson. "It allows you to do chemistry on an exceptionally small scale."

He said the applications could be widespread because the goal of much of modern technology--from biology to electronics-- is to make things as small and as uniform as possible.

Last month, Young and Douglas published a paper on the discovery in the international journal Nature. Since then, the response from the scientific community has been "incredible," said Douglas.

Chemists have been trying to build cage-like structures for years, thinking they would be useful for making materials of unique value or materials that would have unique properties, Douglas said. But the results were mixed. The size wasn't always uniform, and hence, neither were the properties.

Instead of building the cages one molecule at a time, Young and Douglas are stealing them.

"The natural role for that shell is to transport [the virus]," said Young. "It evolved to survive in many different chemical environments. We're just hijacking nature."

Some shells are rod-shaped, some are spheres. Many are well enough studied that scientists know their exact size and shape inside and out.

The shells, or pots, have lids that can open and close, so Young envisions chemicals going into the pot, a chemical reaction occurs, the lid closes, the pot gets transported to another location, the lid opens and out come the contents.

Young said the approach is so new that when the patent application was filed, a patent search yielded nothing even remotely similar.

"The idea was everything," said Young. "It was so obvious once the connection was made that we had to keep quiet about it."

Their collaboration began after Douglas, who until a year ago taught chemistry at MSU-Billings, was looking through a news magazine and saw a picture of HIV. It looked a lot like a protein he studies called ferritin.

"I thought, 'Gee. Maybe they have a similar function'," he recalled. "Both are storage containers. Ferritin stores iron. A virus stores nucleic acids."

Later, he met Young, an internationally known plant virologist.

"I said, 'This is pretty out to lunch, but I need an empty virus'," Douglas recalled.

"The real thinking was, 'Let's not think of the shell as part of the infectious agent,' Young said. 'Let's think of it as a molecular-sized cooking pot, a constrained reaction vessel where the size and shape of the vessel are determined by the virus'."

One application is targeted drug delivery where the pots take the medicine to the correct spot in the body. The team is trying to develop such a system for breast cancer treatment. They just received a $375,000 grant from the National Science Foundation to apply the discovery to medical diagnostics.

"Before this work, no one knew how to make a homogeneous environment for getting all the same size and shape of material," said Young. "This is a huge shift in thinking."


Story Source:

The above story is based on materials provided by Montana State University. Note: Materials may be edited for content and length.


Cite This Page:

Montana State University. "Scientists Excited About Miniature Cooking Pots." ScienceDaily. ScienceDaily, 14 July 1998. <www.sciencedaily.com/releases/1998/07/980714071655.htm>.
Montana State University. (1998, July 14). Scientists Excited About Miniature Cooking Pots. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1998/07/980714071655.htm
Montana State University. "Scientists Excited About Miniature Cooking Pots." ScienceDaily. www.sciencedaily.com/releases/1998/07/980714071655.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins